mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.04 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |